The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122908015 12290801 5 F 20160223 20160912 20160421 20160914 EXP US-PFIZER INC-2016208067 PFIZER 68.00 YR F Y 0.00000 20160914 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122908015 12290801 1 PS LYRICA PREGABALIN 1 100 MG, 3X/DAY 21446 100 MG CAPSULE, HARD TID
122908015 12290801 2 SS LYRICA PREGABALIN 1 150 MG, 3X/DAY 21446 150 MG CAPSULE, HARD TID
122908015 12290801 3 SS LYRICA PREGABALIN 1 450 MG, 1X/DAY, AT BEDTIME 21446 450 MG CAPSULE, HARD QD
122908015 12290801 4 SS LYRICA PREGABALIN 1 100 MG, 3X/DAY, MORNING ,NOON, AND NIGHT 21446 100 MG CAPSULE, HARD TID
122908015 12290801 5 SS NEURONTIN GABAPENTIN 1 Oral 400 MG, 1X/DAY, AT BED 20235 400 MG CAPSULE, HARD QD
122908015 12290801 6 SS NEURONTIN GABAPENTIN 1 Oral 400 MG, 2X/DAY, IN THE MORNING AND AT NIGHT 20235 400 MG CAPSULE, HARD BID
122908015 12290801 7 SS CYMBALTA DULOXETINE HYDROCHLORIDE 1 U 0
122908015 12290801 8 C BRINTELLIX VORTIOXETINE HYDROBROMIDE 1 10 MG, 1X/DAY 0 10 MG QD
122908015 12290801 9 C BRINTELLIX VORTIOXETINE HYDROBROMIDE 1 0
122908015 12290801 10 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 300 MG, 1X/DAY 0 300 MG QD
122908015 12290801 11 C WELLBUTRIN BUPROPION HYDROCHLORIDE 1 0
122908015 12290801 12 C SYNTHROID LEVOTHYROXINE SODIUM 1 150 MG, 1X/DAY 0 150 MG TABLET QD
122908015 12290801 13 C SOTALOL. SOTALOL 1 18 MG, 2X/DAY, MORNING AND AT NIGHT 0 18 MG BID
122908015 12290801 14 C ATORVASTATIN ATORVASTATIN 1 40 MG, 1X/DAY, AT BED TIME 0 40 MG QD
122908015 12290801 15 C ESOMEPRAZOLE MAGNESIUM. ESOMEPRAZOLE MAGNESIUM 1 40 MG, 1X/DAY, IN THE MORNING 0 40 MG QD
122908015 12290801 16 C PEPCID FAMOTIDINE 1 20 MG, 1X/DAY, AT BEDTIME 0 20 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122908015 12290801 1 Pain
122908015 12290801 2 Fibromyalgia
122908015 12290801 5 Sleep disorder
122908015 12290801 6 Pain
122908015 12290801 8 Depression
122908015 12290801 9 Bipolar disorder
122908015 12290801 10 Depression
122908015 12290801 11 Bipolar disorder
122908015 12290801 12 Hypothyroidism
122908015 12290801 13 Supraventricular tachycardia
122908015 12290801 14 Blood cholesterol increased
122908015 12290801 15 Gastrooesophageal reflux disease
122908015 12290801 16 Gastrooesophageal reflux disease

Outcome of event

Event ID CASEID OUTC COD
122908015 12290801 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122908015 12290801 Cardiac failure
122908015 12290801 Drug ineffective for unapproved indication
122908015 12290801 Peripheral swelling
122908015 12290801 Pulmonary mass
122908015 12290801 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
122908015 12290801 2 201601 0
122908015 12290801 5 201601 0
122908015 12290801 6 201604 0